Local Paclitaxel Delivery for Treatment of Peripheral Arterial Disease (Q37871728)

24 August 2017

1 reference

title

Local paclitaxel delivery for treatment of peripheral arterial disease (English)

1 reference

24 August 2017

Local Paclitaxel Delivery for Treatment of Peripheral Arterial Disease (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

1 December 2024

1 reference

Beau M. Hawkins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21540442

1 December 2024

Thomas A. Hennebry

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21540442

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21540442

1 December 2024

publication date

3 May 2011

1 reference

Circulation: Cardiovascular Interventions

24 August 2017

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

297-302

1 reference

Coronary stents: current status

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

The Taxus drug-eluting stent: a new paradigm in controlled drug delivery

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Promotion of microtubule assembly in vitro by taxol

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-coated balloons for the prevention of vascular restenosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Vertebral artery stenting utilizing distal embolic protection with filter wire and a drug-eluting Taxus stent

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting stents for the treatment of vertebral artery origin stenosis.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Symptomatic ostial vertebral artery stenosis: treatment with drug-eluting stents--clinical and angiographic results at 1-year follow-up.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Restenosis rates following vertebral artery origin stenting: does stent type make a difference?

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting stent insertion in the treatment of in-stent renal artery restenosis in three renal transplant recipients

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting stent for recurrent mesenteric artery in-stent restenosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Is drug-eluting stent angioplasty indicated for the treatment of atherosclerotic renal artery stenosis and restenosis?

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Infrapopliteal drug-eluting stents for chronic limb ischemia.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting Tibial Stents: Objective Patency Determination

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting balloon: the comeback kid?

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Successful revascularization of re-stenosis of lower extremity arteries with localized delivery of paclitaxel

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Evolving modalities for femoropopliteal interventions

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

Lesion complexity determines arterial drug distribution after local drug delivery.

1 December 2024

1 reference

https://api.crossref.org/works/10.1161/CIRCINTERVENTIONS.110.961052

1 December 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference